Literature DB >> 27020313

Alcohol produces distinct hepatic lipidome and eicosanoid signature in lean and obese.

Puneet Puri1, Jun Xu2, Terhi Vihervaara3, Riikka Katainen3, Kim Ekroos3, Kalyani Daita4, Hae-Ki Min4, Andrew Joyce5, Faridoddin Mirshahi4, Hidekazu Tsukamoto2, Arun J Sanyal4.   

Abstract

Alcohol- and obesity-related liver diseases often coexist. The hepatic lipidomics due to alcohol and obesity interaction is unknown. We characterized the hepatic lipidome due to 1) alcohol consumption in lean and obese mice and 2) obesity and alcohol interactions. In the French-Tsukamoto mouse model, intragastric alcohol or isocaloric dextrose were fed with either chow (lean) or high-fat, high-cholesterol diet (obese). Four groups (lean, lean alcohol, obese, and obese alcohol) were studied. MS was performed for hepatic lipidomics, and data were analyzed. Alcohol significantly increased hepatic cholesteryl esters and diacyl-glycerol in lean and obese but was more pronounced in obese. Alcohol produced contrasting changes in hepatic phospholipids with significant enrichment in lean mice versus significant decrease in obese mice, except phosphatidylglycerol, which was increased in both lean and obese alcohol groups. Most lysophospholipids were increased in lean alcohol and obese mice without alcohol use only. Prostaglandin E2; 5-, 8-, and 11-hydroxyeicosatetraenoic acids; and 9- and 13-hydroxyoctadecadienoic acids were considerably increased in obese mice with alcohol use. Alcohol consumption produced distinct changes in lean and obese with profound effects of obesity and alcohol interaction on proinflammatory and oxidative stress-related eicosanoids.
Copyright © 2016 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  cyclooxygenase; cytochrome P450; hydroxyeicosatetraenoic acids; lipoxygenase; liver; obesity; phospholipids; prostaglandins

Mesh:

Substances:

Year:  2016        PMID: 27020313      PMCID: PMC4878186          DOI: 10.1194/jlr.M066175

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  50 in total

1.  Lipidomic changes in rat liver after long-term exposure to ethanol.

Authors:  Harshica Fernando; Kamlesh K Bhopale; Shakuntala Kondraganti; Bhupendra S Kaphalia; G A Shakeel Ansari
Journal:  Toxicol Appl Pharmacol       Date:  2011-06-26       Impact factor: 4.219

2.  Phosphatidylcholine synthesis for lipid droplet expansion is mediated by localized activation of CTP:phosphocholine cytidylyltransferase.

Authors:  Natalie Krahmer; Yi Guo; Florian Wilfling; Maximiliane Hilger; Susanne Lingrell; Klaus Heger; Heather W Newman; Marc Schmidt-Supprian; Dennis E Vance; Matthias Mann; Robert V Farese; Tobias C Walther
Journal:  Cell Metab       Date:  2011-10-05       Impact factor: 27.287

3.  Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibition.

Authors:  Brandon T Larsen; Hiroto Miura; Ossama A Hatoum; William B Campbell; Bruce D Hammock; Darryl C Zeldin; John R Falck; David D Gutterman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-10-28       Impact factor: 4.733

4.  Downregulation of JAK3 protein levels in T lymphocytes by prostaglandin E2 and other cyclic adenosine monophosphate-elevating agents: impact on interleukin-2 receptor signaling pathway.

Authors:  V Kolenko; P Rayman; B Roy; M K Cathcart; J O'Shea; R Tubbs; L Rybicki; R Bukowski; J Finke
Journal:  Blood       Date:  1999-04-01       Impact factor: 22.113

5.  Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis.

Authors:  Harmeet Malhi; Steven F Bronk; Nathan W Werneburg; Gregory J Gores
Journal:  J Biol Chem       Date:  2006-02-27       Impact factor: 5.157

6.  Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.

Authors:  Arun J Sanyal; Naga Chalasani; Kris V Kowdley; Arthur McCullough; Anna Mae Diehl; Nathan M Bass; Brent A Neuschwander-Tetri; Joel E Lavine; James Tonascia; Aynur Unalp; Mark Van Natta; Jeanne Clark; Elizabeth M Brunt; David E Kleiner; Jay H Hoofnagle; Patricia R Robuck
Journal:  N Engl J Med       Date:  2010-04-28       Impact factor: 91.245

7.  Endpoints and clinical trial design for nonalcoholic steatohepatitis.

Authors:  Arun J Sanyal; Elizabeth M Brunt; David E Kleiner; Kris V Kowdley; Naga Chalasani; Joel E Lavine; Vlad Ratziu; Arthur McCullough
Journal:  Hepatology       Date:  2011-07       Impact factor: 17.425

8.  Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice.

Authors:  Yangmei Deng; Matthew L Edin; Katherine N Theken; Robert N Schuck; Gordon P Flake; M Alison Kannon; Laura M DeGraff; Fred B Lih; Julie Foley; J Alyce Bradbury; Joan P Graves; Kenneth B Tomer; John R Falck; Darryl C Zeldin; Craig R Lee
Journal:  FASEB J       Date:  2010-11-08       Impact factor: 5.191

9.  Inhibitory effect of ethanol on AMPK phosphorylation is mediated in part through elevated ceramide levels.

Authors:  Suthat Liangpunsakul; Margaret S Sozio; Eric Shin; Zhenwen Zhao; Yan Xu; Ruth A Ross; Yan Zeng; David W Crabb
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-03-11       Impact factor: 4.052

10.  A nuclear-receptor-dependent phosphatidylcholine pathway with antidiabetic effects.

Authors:  Jae Man Lee; Yoon Kwang Lee; Jennifer L Mamrosh; Scott A Busby; Patrick R Griffin; Manish C Pathak; Eric A Ortlund; David D Moore
Journal:  Nature       Date:  2011-05-25       Impact factor: 49.962

View more
  8 in total

1.  Serum and Fecal Oxylipins in Patients with Alcohol-Related Liver Disease.

Authors:  Peter Stärkel; Bernd Schnabl; Bei Gao; Sonja Lang; Yi Duan; Yanhan Wang; Debbie L Shawcross; Alexandre Louvet; Philippe Mathurin; Samuel B Ho
Journal:  Dig Dis Sci       Date:  2019-05-10       Impact factor: 3.487

Review 2.  Xenobiotic-Induced Aggravation of Metabolic-Associated Fatty Liver Disease.

Authors:  Julie Massart; Karima Begriche; Anne Corlu; Bernard Fromenty
Journal:  Int J Mol Sci       Date:  2022-01-19       Impact factor: 5.923

3.  Myriocin Treatment Reverses Alcohol-Induced Alterations in Polyunsaturated Fatty Acid-Containing Phospholipid Expression in the Liver.

Authors:  Emine B Yalcin; Ming Tong; Camilla Homans; Suzanne M de la Monte
Journal:  Nutr Metab Insights       Date:  2022-02-28

4.  Linoleic Acid-Derived Oxylipins Differentiate Early Stage Alcoholic Hepatitis From Mild Alcohol-Associated Liver Injury.

Authors:  Dennis Warner; Vatsalya Vatsalya; Kara H Zirnheld; Jeffrey B Warner; Josiah E Hardesty; John C Umhau; Craig J McClain; Krishnarao Maddipati; Irina A Kirpich
Journal:  Hepatol Commun       Date:  2021-02-09

5.  Ethanol and unsaturated dietary fat induce unique patterns of hepatic ω-6 and ω-3 PUFA oxylipins in a mouse model of alcoholic liver disease.

Authors:  Dennis R Warner; Huilin Liu; Shubha Ghosh Dastidar; Jeffrey B Warner; Md Aminul Islam Prodhan; Xinmin Yin; Xiang Zhang; Ariel E Feldstein; Bin Gao; Russell A Prough; Craig J McClain; Irina A Kirpich
Journal:  PLoS One       Date:  2018-09-26       Impact factor: 3.240

6.  Variations in hepatic lipid species of age-matched male mice fed a methionine-choline-deficient diet and housed in different animal facilities.

Authors:  Lisa Rein-Fischboeck; Elisabeth M Haberl; Rebekka Pohl; Susanne Feder; Gerhard Liebisch; Sabrina Krautbauer; Christa Buechler
Journal:  Lipids Health Dis       Date:  2019-09-14       Impact factor: 3.876

7.  Transcriptional signatures of the small intestinal mucosa in response to ethanol in transgenic mice rich in endogenous n3 fatty acids.

Authors:  Josiah E Hardesty; Jeffrey B Warner; Ying L Song; Eric C Rouchka; Chih-Yu Chen; Jing X Kang; Craig J McClain; Dennis R Warner; Irina A Kirpich
Journal:  Sci Rep       Date:  2020-11-16       Impact factor: 4.379

8.  Alcohol and Liver Clock Disruption Increase Small Droplet Macrosteatosis, Alter Lipid Metabolism and Clock Gene mRNA Rhythms, and Remodel the Triglyceride Lipidome in Mouse Liver.

Authors:  Jennifer A Valcin; Uduak S Udoh; Telisha M Swain; Kelly K Andringa; Chirag R Patel; Sameer Al Diffalha; Paul R S Baker; Karen L Gamble; Shannon M Bailey
Journal:  Front Physiol       Date:  2020-09-07       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.